Cibc World Markets Corp Buys 925 Shares of Teleflex Incorporated (NYSE:TFX)

Cibc World Markets Corp grew its stake in shares of Teleflex Incorporated (NYSE:TFX) by 14.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,340 shares of the medical technology company’s stock after acquiring an additional 925 shares during the period. Cibc World Markets Corp’s holdings in Teleflex were worth $1,306,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. HighTower Advisors LLC grew its holdings in Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after purchasing an additional 66 shares during the period. Hengehold Capital Management LLC lifted its position in shares of Teleflex by 7.3% during the 4th quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock valued at $229,000 after buying an additional 88 shares during the last quarter. Exchange Traded Concepts LLC grew its stake in shares of Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock worth $61,000 after acquiring an additional 94 shares during the period. Avior Wealth Management LLC increased its holdings in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 101 shares during the last quarter. Finally, Isthmus Partners LLC raised its stake in Teleflex by 7.3% in the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock valued at $273,000 after acquiring an additional 105 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Stock Up 1.7 %

Shares of NYSE TFX opened at $141.77 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The business has a 50-day moving average of $163.17 and a 200-day moving average of $194.40. The firm has a market capitalization of $6.57 billion, a price-to-earnings ratio of 28.19, a PEG ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 12 month low of $128.55 and a 12 month high of $249.91.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s dividend payout ratio is currently 95.77%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on TFX shares. Royal Bank of Canada downgraded shares of Teleflex from an “outperform” rating to a “sector perform” rating and reduced their target price for the stock from $220.00 to $155.00 in a research note on Friday, February 28th. Raymond James cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Teleflex presently has a consensus rating of “Hold” and an average price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.